U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944430) titled 'Clinician-Selected FSH Starting Dose and Mature Oocyte Yield in Predicted Poor Responders' on Nov. 11.
Brief Summary: This is a single-centre, prospective, non-interventional (observational) cohort study examining the association between the clinician-selected starting dose of follicle-stimulating hormone (FSH) and the yield of mature metaphase II (MII) oocytes in women with predicted poor ovarian response (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number [POSEIDON] group 3 or 4) undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) with a gonadotropin-releasing hormone (GnRH) antago...